# Study to Investigate the Pharmacokinetics and Safety of Cadazolid in Patients With Clostridium Difficile Infection

> **NCT02053181** · PHASE1 · COMPLETED · sponsor: **Actelion** · enrollment: 6 (actual)

## Conditions studied

- Clostridium Difficile Infection

## Interventions

- **DRUG:** Cadazolid

## Key facts

- **NCT ID:** NCT02053181
- **Lead sponsor:** Actelion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2014-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02053181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02053181, "Study to Investigate the Pharmacokinetics and Safety of Cadazolid in Patients With Clostridium Difficile Infection". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02053181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*